🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06094569
Recruiting Observational

Medical Imaging Screening for Posterior-circulation Ischemic Stroke

NCT06094569 · tracked via the Priya Life Science China tracker
Sponsor
Tianjin Huanhu Hospital
Phase
Observational
Started
2019-06-01
Last updated
2023-10-23

Condition(s) studied

Endovascular Thrombectomy

Investigational drug(s) / intervention(s)

Endovascular Therapy

Endovascular Therapy: Endovascular therapy, as an adjunct to standard stroke therapy, may be beneficial for a very select population of patients who present with an acute ischemic stroke and have a proven large, proximal occlusion on imaging. Endovascular therapy includes any one or more of the following: Intra-arterial thrombolytic therapy, aspiration, stent retrieval, or a combination of multiple mechanical devices

Study summary

Patients with ischemic stroke in the posterior circulation continue to have high rates of mortality and disability, even with aggressive treatment. We wanted to evaluate preoperative imaging to screen patients with a good prognosis from mechanical embolization. We assess the degree of ischemia by defining the pons-midbrain-medulla index (PMMI) and correlate the preoperative PMMI with the clinical prognosis of postoperative patients to verify the validity of PMMI in predicting the clinical prognosis of patients with embolization.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patient admitted from Jun. 1st 2019 to Jan. 1st 2029; 2. Patients with acute ischemic stroke recently; 3. Symptoms persisted at admission, and MRI (including DWI) confirmed acute ischemic vertebrobasilar artery occlusion in the posterior circulation:(single right or left intracranial branch of vertebral artery occlusion ; single basilar occlusion ; both two vertebral arterys and basilar artery); Exclusion Criteria: 1.Patiens can not meet the MRI examination conditions(with absolute and relative contraindications).

Primary outcome measure(s)

Trial sites (4)

FacilityCityRegionStatus
Tianjin Medical University General Hospital Tianjin Tianjin Municipality Recruiting
The Sencond Hospital of Tianjin Medical University Tianjin Tianjin Municipality Recruiting
Tianjin Huanhu Hospital Tianjin Tianjin Municipality Recruiting
Beijing University Binhai Hospital Tianjin Tianjin Municipality Recruiting

More Tianjin Huanhu Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06094569 on ClinicalTrials.gov ↗ ← All trials in China